A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Compounding and the Courts

Author(s):  Gibbs Jeffrey N, Wasserstein Jeffrey N

Issue:  Jul/Aug 2002 - Compounding for BHRT and Legal and Regulatory Issues
View All Articles in Issue

Page(s):  263-266

Related Articles from IJPC
Title/Author (Click for Abstract / Details / Purchase)	Issue/​Page View/Buy
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Blankenship Cynthia E	Sep/Oct 2014 Pg. 379-380
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Cabaleiro Joe	Sep/Oct 2021 Pg. 358-362
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Compounding and the Courts Gibbs Jeffrey N, Wasserstein Jeffrey N	Jul/Aug 2002 Pg. 263-266
Basics of Compounding for Terrorist Attacks, Part 2 Allen Loyd V Jr	Mar/Apr 2003 Pg. 129-134 View Sample
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr	Jan/Feb 2018 Pg. 7-16
Current Topical Treatments in Wound Healing - Part 1 Helmke Christopher D	Jul/Aug 2004 Pg. 269-274
Performance Improvement in 503A Compounding Pharmacies: A Plan for Assessment, Implementation, and Sustained Success Pritchett Jon, Mixon William, O'Connell Kevin	Jan/Feb 2016 Pg. 29-36
Pharmacogenomics: Precision Pharmacy in 503A Compounding Drummond Joseph, Bennet Daron, Allen Loyd V Jr	Mar/Apr 2018 Pg. 95-107
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc	Jan/Feb 2014 Pg. 6-12
Basics of Compounding for Cold Sores or Fever Blisters Allen Loyd V Jr	May/Jun 2004 Pg. 206-209
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug	Mar/Apr 2017 Pg. 95-102
Microbiologic Testing for 503A Sterile-Compounding Pharmacies Mixon William, Roth Abby	May/Jun 2017 Pg. 193-203
FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns Allen Loyd V Jr	Jan/Feb 1999 Pg. 25-29
Quality Control: Lessons Learned from a Trimix Stability Study in a 503A Compounding Pharmacy Rhoads Rick	Mar/Apr 2018 Pg. 129-134
Compounding OTC Drugs: A Legal Perspective Gibbs Jeffrey N, Mazan Kate Duffy	May/Jun 2000 Pg. 180-181
A Simplified Method for Compounding Lidocaine Topical Gel: A Demonstration of Quality Assurance to Prevent Errors in 503A Pharmacies Hall Essence, Levesque Dan, Rashid Mamoon, Mullins Randy, Hossain Mohammad Faisal	May/Jun 2021 Pg. 197-204
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum Zur Eyal	Mar/Apr 2012 Pg. 117-124
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K	Jan/Feb 2013 Pg. 74-85 View Sample
Return to Top